Caris Life Sciences to Showcase 19 Studies at the 2025 San Antonio Breast Cancer Symposium
Caris Life Sciences®(NASDAQ: CAI), a leading, patient-centric, next-generation AI TechBio company and precision medicine pioneer,today announced that the company and collaborators from leading cancer centers, including those within the Caris Precision Oncology Alliance™ (Caris POA), will collectively present 19 studies across a range of breast cancer types at the San Antonio Breast Cancer Symposium (SABCS) […]